These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3429691)

  • 1. Patient-initiated postmarketing surveillance: a validation study.
    Fisher S; Bryant SG; Solovitz BL; Kluge RM
    J Clin Pharmacol; 1987 Nov; 27(11):843-54. PubMed ID: 3429691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to postmarketing surveillance.
    Fisher S; Bryant SG; Kluge RM
    Psychopharmacology (Berl); 1986; 90(3):347-50. PubMed ID: 3097723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing surveillance of adverse drug reactions: patient self-monitoring.
    Fisher S; Bryant SG
    J Am Board Fam Pract; 1992; 5(1):17-25. PubMed ID: 1561919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age on reporting of adverse clinical events: results from two postmarketing surveillance methods.
    Bryant SG; Fisher S; Prinsley DM; Olins NJ; Larson DB
    Pharmacotherapy; 1991; 11(3):249-55. PubMed ID: 1862016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence and therapeutic relevance of the adverse effects of antidepressive agents within the scope of ambulatory neurologic treatment].
    Schmidt LG; Schüssler G; Linden M; Müller-Oerlinghausen B
    Fortschr Neurol Psychiatr; 1988 Apr; 56(4):111-8. PubMed ID: 3384381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.
    Golomb BA; McGraw JJ; Evans MA; Dimsdale JE
    Drug Saf; 2007; 30(8):669-75. PubMed ID: 17696579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmarketing surveillance: accuracy of patient drug attribution judgments.
    Fisher S; Bryant SG
    Clin Pharmacol Ther; 1990 Jul; 48(1):102-7. PubMed ID: 2369805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of medication use, compliance and symptoms of hypotension in a community-based sample of elderly men and women.
    Cohen I; Rogers P; Burke V; Beilin LJ
    J Clin Pharm Ther; 1998 Dec; 23(6):423-32. PubMed ID: 10048503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
    Curtis LH; Østbye T; Sendersky V; Hutchison S; Allen LaPointe NM; Al-Khatib SM; Usdin Yasuda S; Dans PE; Wright A; Califf RM; Woosley RL; Schulman KA
    Am J Med; 2003 Feb; 114(2):135-41. PubMed ID: 12586234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reactions to first- and second-generation antidepressants: a critical evaluation of drug surveillance data.
    Schmidt LG; Grohmann R; Müller-Oerlinghausen B; Ochsenfahrt H; Schönhöfer PS
    Br J Psychiatry; 1986 Jan; 148():38-43. PubMed ID: 2937504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ED prescription dispensing on patient compliance.
    Ginde AA; Von Harz BC; Turnbow D; Lewis LM
    Am J Emerg Med; 2003 Jul; 21(4):313-5. PubMed ID: 12898489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: a comparison regarding patients and drugs.
    Egberts AC; de Koning FH; Meyboom RH; Leufkens HG
    Pharmacoepidemiol Drug Saf; 1997 Jul; 6(4):269-76. PubMed ID: 15073778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient reporting of adverse drug reactions: useful information for pain management?
    Jarernsiripornkul N; Krska J; Richards RM; Capps PA
    Eur J Pain; 2003; 7(3):219-24. PubMed ID: 12725844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative risk of vaginal candidiasis after use of antibiotics compared with antidepressants in women: postmarketing surveillance data in England.
    Wilton L; Kollarova M; Heeley E; Shakir S
    Drug Saf; 2003; 26(8):589-97. PubMed ID: 12825971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring New Zealand prescription data using sequence symmetry analyses for predicting adverse drug reactions.
    Nishtala PS; Chyou TY
    J Clin Pharm Ther; 2017 Apr; 42(2):189-194. PubMed ID: 27957745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
    Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug safety warnings in psychiatry: adverse drug reactions' signaling from 2002 to 2014].
    Prisco V; Iannaccone T; Tusciano A; Boccardi M; Perris F; Capuano A; Catapano F; Fabrazzo M
    Riv Psichiatr; 2016; 51(3):96-103. PubMed ID: 27362820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause.
    Passarelli MC; Jacob-Filho W; Figueras A
    Drugs Aging; 2005; 22(9):767-77. PubMed ID: 16156680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.